Hospira
Hospira Recalls Naloxone Product
Hospira issued a voluntary recall of one of its naloxone products because of it might contain loose particulate ...
JUNE 5, 2018
First Epoetin alfa Biosimilar Receives FDA Approval for Anemia
Retacrit is the first U.S. biosimilar erythropoiesis-stimulating agent (ESA). Although not listed as an ...
MAY 15, 2018
Load more